Literature DB >> 13446477

TOLBUTAMIDE in diabetes.

.   

Abstract

Entities:  

Keywords:  DIABETES MELLITUS/therapy; SULFONAMIDES/therapeutic use; UREA/related compounds

Mesh：

Substances：

Year:  1957        PMID： 13446477      PMCID： PMC1962017     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  8 in total

1.  Some remarks on the mechanism of action of the sulfonylureas.

Authors:  S A BERSON; R S YALOW
Journal:  Diabetes       Date:  1957 May-Jun       Impact factor: 9.461

2.  On the action of BZ-55 and D-860 in pancreatectomized dogs.

Authors:  P SCHAMBYE
Journal:  Diabetes       Date:  1957 Mar-Apr       Impact factor: 9.461

3.  The use of orinase in diabetes.

Authors:  S B BEASER
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

4.  Clinical experience with orinase.

Authors:  H DOLGER
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

5.  Intrapancreatic perfusion of the antidiabetic sulfonylureas.

Authors:  A R COLWELL; A R COLWELL; J A COLWELL
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

6.  Comparative effects of insulin and orinase on blood levels of pyruvate and alpha-ketoglutarate in normal subjects.

Authors:  J W CONN; S S FAJANS; A R HENNES; B L WAJCHENBERG
Journal:  Metabolism       Date:  1957-01       Impact factor: 8.694

7.  Occurrence of sensitivity and side reactions following carbutamide.

Authors:  W R KIRTLEY
Journal:  Diabetes       Date:  1957 Jan-Feb       Impact factor: 9.461

8.  [Oral therapy of diabetes mellitus by N-tolyl-sulfonyl-N'-butyl urea (D 860); clinical and experimental studies].

Authors:  A BANDER; W CREUTZFELDT; T DORFMULLER; H EHRHART; R MARX; H MASKE; W MEIER; G MOHNIKE; E F PFEIFFER; S SCHLAGINTWEIT; K SCHOFFLING; J SCHOLZ; I SEIDLER; H STEIGERWALD; W STICH; G STOTTER; H ULRICH
Journal:  Dtsch Med Wochenschr       Date:  1956-05-25       Impact factor: 0.628
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.